Shenzhen - Delayed Quote CNY

Dian Diagnostics Group Co.,Ltd. (300244.SZ)

14.25
-0.51
(-3.46%)
At close: 3:04:37 PM GMT+8
Loading Chart for 300244.SZ
  • Previous Close 14.76
  • Open 14.90
  • Bid 14.26 x --
  • Ask 14.27 x --
  • Day's Range 14.20 - 14.69
  • 52 Week Range 8.90 - 21.75
  • Volume 18,128,700
  • Avg. Volume 30,885,316
  • Market Cap (intraday) 8.906B
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) --
  • EPS (TTM) -0.65
  • Earnings Date --
  • Forward Dividend & Yield 0.71 (4.81%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 11.90

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment. In addition, the company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions; multi-omics platform services; DP-TOF nucleic acid mass spectrometry solutions; and forensic drug testing products. Further, it provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.

www.dazd.cn

8,773

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300244.SZ

View More

Performance Overview: 300244.SZ

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300244.SZ
25.55%
SSE Composite Index (000001.SS)
0.85%

1-Year Return

300244.SZ
7.84%
SSE Composite Index (000001.SS)
7.02%

3-Year Return

300244.SZ
51.64%
SSE Composite Index (000001.SS)
7.42%

5-Year Return

300244.SZ
34.17%
SSE Composite Index (000001.SS)
20.13%

Compare To: 300244.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300244.SZ

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    9.22B

  • Enterprise Value

    10.92B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.78

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    0.94

  • Enterprise Value/EBITDA

    186.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.46%

  • Return on Assets (ttm)

    1.72%

  • Return on Equity (ttm)

    -2.59%

  • Revenue (ttm)

    11.59B

  • Net Income Avi to Common (ttm)

    -401.45M

  • Diluted EPS (ttm)

    -0.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.69B

  • Total Debt/Equity (mrq)

    38.79%

  • Levered Free Cash Flow (ttm)

    1.09B

Research Analysis: 300244.SZ

View More

Company Insights: 300244.SZ

Research Reports: 300244.SZ

View More

People Also Watch